Clinical trial

Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis

NCT01404429

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE4

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

MethotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Post Graduate Institute of Medical Education and Research, Chandigarhlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01404429 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.